Search

Atypical MHC class II-expressing antigen-presenting cells: can

4.7 (577) · $ 14.99 · In stock

Atypical MHC class II-expressing antigen-presenting cells: can
Antigen-presenting fibroblasts sustain anti-tumour CD4+ T cells in

Antigen-presenting fibroblasts sustain anti-tumour CD4+ T cells in

Biological Consequences of MHC-II Expression by Tumor Cells in Cancer. -  Abstract - Europe PMC

Biological Consequences of MHC-II Expression by Tumor Cells in Cancer. - Abstract - Europe PMC

Antigen presentation safeguards the integrity of the hematopoietic stem  cell pool - ScienceDirect

Antigen presentation safeguards the integrity of the hematopoietic stem cell pool - ScienceDirect

Dendritic Cells  Musculoskeletal Key

Dendritic Cells Musculoskeletal Key

Ubiquitin-like protein 3 (UBL3) is required for MARCH ubiquitination of  major histocompatibility complex class II and CD86

Ubiquitin-like protein 3 (UBL3) is required for MARCH ubiquitination of major histocompatibility complex class II and CD86

Model of transcriptional regulation of MHC class I and class II

Model of transcriptional regulation of MHC class I and class II

Dendritic Cell Overview  Thermo Fisher Scientific - CI

Dendritic Cell Overview Thermo Fisher Scientific - CI

Cells, Free Full-Text

Cells, Free Full-Text

Frontiers  IFNγ-Induced MHC Class II Expression on Islet

Frontiers IFNγ-Induced MHC Class II Expression on Islet

Atypical MHC class II-expressing antigen-presenting cells: can

Atypical MHC class II-expressing antigen-presenting cells: can

Present Yourself! By MHC Class I and MHC Class II Molecules

Present Yourself! By MHC Class I and MHC Class II Molecules

Genetic Control of MHC Class II Expression: Cell

Genetic Control of MHC Class II Expression: Cell

Frontiers  Antigen-Presenting Cell-Like Neutrophils Foster T Cell Response  in Hyperlipidemic Patients and Atherosclerotic Mice

Frontiers Antigen-Presenting Cell-Like Neutrophils Foster T Cell Response in Hyperlipidemic Patients and Atherosclerotic Mice

The known unknowns of antigen processing and presentation

The known unknowns of antigen processing and presentation

MHC heterogeneity and response of metastases to immunotherapy

MHC heterogeneity and response of metastases to immunotherapy